Aeon: Pioneering Preventive Healthcare with €8.2 Million Seed Round
June 6, 2025, 10:25 pm
In a world where health often takes a backseat, Aeon is driving the future of preventive care. The Swiss startup has secured €8.2 million in a seed funding round, setting the stage for a healthcare revolution. This funding, led by Concentric, aims to transform how we approach health management.
Aeon’s mission is clear: shift from reactive healthcare to proactive health management. The company offers a comprehensive check-up that integrates full-body MRI scans, advanced blood biomarker analysis, and genetic testing—all within a single 60-minute session. This is not just a check-up; it’s a health awakening.
Imagine a world where you can detect over 500 diseases before they become life-threatening. Aeon makes this possible. Their approach combines cutting-edge technology with a human touch. Board-certified physicians review results, and patients discuss findings directly with radiologists. This ensures clarity and confidence in every diagnosis.
False positives plague the healthcare industry. They lead to unnecessary stress and procedures. Aeon stands out with a 0% false positive rate in clinical-grade follow-ups. This is a beacon of hope in a field often clouded by uncertainty. The company’s use of AI enhances accuracy. Automated imaging analysis detects anomalies in MRI scans. Cross-validation correlates MRI, blood, and genetic data, reducing false positives. Predictive modeling creates personalized risk profiles, forecasting health risks tailored to each individual.
Since its launch in 2024, Aeon has already made significant strides. Early-stage cancers, aneurysms, and Alzheimer’s have been detected in patients who felt perfectly healthy. One notable case involved a 56-year-old man whose kidney cancer was identified through a single scan. This early detection enabled life-saving surgery. Such stories underscore the importance of proactive health management.
Aeon is not just another health platform. It is the first to offer full-body check-ups eligible for reimbursement by health insurers. Partnerships with Switzerland’s largest insurance providers, including KPT, allow customers to reclaim up to 80% of their costs. This sets a new standard for accessible healthcare.
The founding team behind Aeon is impressive. CEO Tim Seithe previously founded and sold Tillhub, while CPO Samuel Frey has a decade of product leadership experience. They are joined by Dr. Andreas Lemke, a leading MRI physicist. Together, they form a powerhouse of innovation and expertise.
The funding round attracted attention from notable investors. Concentric led the charge, joined by Calm/Storm Ventures, GoHub Ventures, Kadmos Capital, EWOR, and Swiss super angel investor Daniel Gutenberg. Their belief in Aeon’s potential is palpable. They see a rare combination of clinical rigor and commercial scalability.
The new capital will fuel Aeon’s expansion across Switzerland, Germany, and the UK. Plans for further international markets are already in the pipeline. This growth will enhance partnerships with insurers and employers, improving access and affordability. Aeon also aims to open more than 10 new locations in the coming months, scaling its clinical network to reach more patients.
The statistics surrounding chronic diseases are alarming. According to the Global Alliance for Chronic Diseases, 41 million people die each year from non-communicable diseases. This number is projected to rise by 27% by 2030. Yet, 80% of these deaths are preventable. Aeon aims to bridge the gap between fragmented data and effective prevention.
The healthcare landscape is changing. Aeon is at the forefront of this transformation. By harnessing the power of AI and advanced diagnostics, they are redefining what it means to be proactive about health. The company’s innovative approach empowers individuals to take control of their health journeys.
In a world where time is of the essence, Aeon offers a solution that is both efficient and effective. The 60-minute check-up is a small investment for a lifetime of health. With each scan, patients gain insights that can change their lives.
As Aeon continues to grow, the potential impact on public health is immense. The integration of advanced technology with personalized care could reshape the future of healthcare. It’s a bold vision, but one that is grounded in reality.
In conclusion, Aeon is not just a startup; it’s a movement. A movement towards a healthier future. With €8.2 million in funding, they are poised to make waves in the healthcare industry. The journey has just begun, but the destination is clear: a world where preventive care is the norm, not the exception. Aeon is leading the charge, and the future looks bright.
Aeon’s mission is clear: shift from reactive healthcare to proactive health management. The company offers a comprehensive check-up that integrates full-body MRI scans, advanced blood biomarker analysis, and genetic testing—all within a single 60-minute session. This is not just a check-up; it’s a health awakening.
Imagine a world where you can detect over 500 diseases before they become life-threatening. Aeon makes this possible. Their approach combines cutting-edge technology with a human touch. Board-certified physicians review results, and patients discuss findings directly with radiologists. This ensures clarity and confidence in every diagnosis.
False positives plague the healthcare industry. They lead to unnecessary stress and procedures. Aeon stands out with a 0% false positive rate in clinical-grade follow-ups. This is a beacon of hope in a field often clouded by uncertainty. The company’s use of AI enhances accuracy. Automated imaging analysis detects anomalies in MRI scans. Cross-validation correlates MRI, blood, and genetic data, reducing false positives. Predictive modeling creates personalized risk profiles, forecasting health risks tailored to each individual.
Since its launch in 2024, Aeon has already made significant strides. Early-stage cancers, aneurysms, and Alzheimer’s have been detected in patients who felt perfectly healthy. One notable case involved a 56-year-old man whose kidney cancer was identified through a single scan. This early detection enabled life-saving surgery. Such stories underscore the importance of proactive health management.
Aeon is not just another health platform. It is the first to offer full-body check-ups eligible for reimbursement by health insurers. Partnerships with Switzerland’s largest insurance providers, including KPT, allow customers to reclaim up to 80% of their costs. This sets a new standard for accessible healthcare.
The founding team behind Aeon is impressive. CEO Tim Seithe previously founded and sold Tillhub, while CPO Samuel Frey has a decade of product leadership experience. They are joined by Dr. Andreas Lemke, a leading MRI physicist. Together, they form a powerhouse of innovation and expertise.
The funding round attracted attention from notable investors. Concentric led the charge, joined by Calm/Storm Ventures, GoHub Ventures, Kadmos Capital, EWOR, and Swiss super angel investor Daniel Gutenberg. Their belief in Aeon’s potential is palpable. They see a rare combination of clinical rigor and commercial scalability.
The new capital will fuel Aeon’s expansion across Switzerland, Germany, and the UK. Plans for further international markets are already in the pipeline. This growth will enhance partnerships with insurers and employers, improving access and affordability. Aeon also aims to open more than 10 new locations in the coming months, scaling its clinical network to reach more patients.
The statistics surrounding chronic diseases are alarming. According to the Global Alliance for Chronic Diseases, 41 million people die each year from non-communicable diseases. This number is projected to rise by 27% by 2030. Yet, 80% of these deaths are preventable. Aeon aims to bridge the gap between fragmented data and effective prevention.
The healthcare landscape is changing. Aeon is at the forefront of this transformation. By harnessing the power of AI and advanced diagnostics, they are redefining what it means to be proactive about health. The company’s innovative approach empowers individuals to take control of their health journeys.
In a world where time is of the essence, Aeon offers a solution that is both efficient and effective. The 60-minute check-up is a small investment for a lifetime of health. With each scan, patients gain insights that can change their lives.
As Aeon continues to grow, the potential impact on public health is immense. The integration of advanced technology with personalized care could reshape the future of healthcare. It’s a bold vision, but one that is grounded in reality.
In conclusion, Aeon is not just a startup; it’s a movement. A movement towards a healthier future. With €8.2 million in funding, they are poised to make waves in the healthcare industry. The journey has just begun, but the destination is clear: a world where preventive care is the norm, not the exception. Aeon is leading the charge, and the future looks bright.